• Register
  • Login
  • Subscribe
  • Contact Us

Medicines with the Active Ingredient Combination Tamsulosin and Dutastasteride (Atc: G04ca52)

GermanyTenders notice for Medicines with the Active Ingredient Combination Tamsulosin and Dutastasteride (Atc: G04ca52). The reference ID of the tender is 117491640 and it is closing on 30 Nov 2025.

Tender Details

  • Country: Germany
  • Summary: Medicines with the Active Ingredient Combination Tamsulosin and Dutastasteride (Atc: G04ca52)
  • DET Ref No: 117491640
  • Deadline: 30 Nov 2025
  • Financier: Self Financed
  • Purchaser Ownership: Government
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: 232455-2025
  • Purchaser's Detail:
    Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
  • Description:
  • The subject of this publication is the conclusion of non-exclusive discount contracts in accordance with Section 130a (8) SGB V for finished medicinal products with the active ingredient combination Tamsulosin and Dutasteride (ATC: G04CA52) as part of a so-called "open house model". Under the specification of uniform contractual termsAs well as a uniform access procedure, all suitable and interested pharmaceutical companies or communities of pharmaceutical companies are offered the conclusion or accession to a discount contract according to ยง 130a (8) SGB V for the aforementioned active substances or drugs.Interested pharmaceutical companies can request the participation documents and the respective contract at the contact address mentioned. The prerequisite for the conclusion of a contract is that the interested pharmaceutical company fullyFilled and signed.Final possibility in the context of a so-called "open house model". A contract is concluded with every pharmaceutical company that meets the prerequisites for participation. There is no exclusivity. The accession or the contract can be concluded at any time and to theg...
  • Documents:

 Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN

Medicines with the Active Ingredient Combination Tamsulosin and Dutastasteride (Atc: G04ca52) - Germany Tender

The AOK SAXONY - ANHALT, a Government sector organization in Germany, has announced a new tender for Medicines with the Active Ingredient Combination Tamsulosin and Dutastasteride (Atc: G04ca52). This tender is published on GermanyTenders under DET Ref No: 117491640 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-11-30.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.

GermanyTenders Features

GermanyTenders Features

Fresh and verified Tenders from Germany. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • New Tenders Every Day
  • Tenders Result Data
  • Archive & Historical Tenders Access
  • Consultants for RFI/RFP/RFQ
  • Tender Notifications & Alerts
  • Search, Sort, and Filter Tenders
  • Bidding Assistance & Consulting
  • Customer Support
  • Publish your Tenders
  • Export data to Excel
  • API for Tender Data
  • Tender Documents
Tender Experts

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting GermanyTenders !!
Email Id is already exist !!
Captcha Image
Invalid Captcha !

Get FREE SAMPLE TENDERS from Germany in your email inbox.

  Chat with us